Novartis AG NVS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:36 PM EST
87.56quote price arrow down-0.61 (-0.69%)
Volume
1,401,141
52 week range
69.18 - 98.52

...

Loading . . .

KEY STATS

  • Open88.00
  • Day High88.21
  • Day Low86.91
  • Prev Close88.17
  • 52 Week High98.52
  • 52 Week High Date01/25/21
  • 52 Week Low69.18
  • 52 Week Low Date03/16/20
  • Market Cap216.016B
  • Shares Out2.467B
  • 10 Day Average Volume2.02M
  • Dividend3.38
  • Dividend Yield3.86%
  • Beta0.59
  • 1 Year % Change4.71

RATIOS/PROFITABILITY

  • EPS (TTM)3.52
  • P/E (TTM)24.90
  • Fwd P/E (NTM)13.70
  • EBITDA (MRQ)18.476B
  • ROE (MRQ)14.41%
  • Revenue (MRQ)49.898B
  • Gross Margin (MRQ)71.14%
  • Net Margin (MRQ)16.18%
  • Debt To Equity (MRQ)67.23%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date03/04/2021
  • Div Amount3.3784
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...
Joerg Reinhardt Ph.D.
Non-Executive Chairman
Vasant Narasimhan M.D.
Chief Executive Officer
Harry Kirsch
Chief Financial Officer
Steffen Lang Ph.D.
Chief Technology Officer
Address
Lichtstrasse 35
Basel
4056
Switzerland